Arrowhead Pharmaceuticals (ARWR) Net Equity Issued and Repurchased (2010 - 2026)
Arrowhead Pharmaceuticals' (ARWR) quarterly Net Equity Issued and Repurchased came in at -$44000.0 in Q1 2026, down 100.02% YoY from $241.4 million in Q1 2025, and down 100.09% on a QoQ basis from $48.2 million in Q4 2025.
Arrowhead Pharmaceuticals (ARWR) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 12 years of Net Equity Issued and Repurchased data on file, last reported at -$44000.0 in Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 100.02% year-over-year to -$44000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.2 million (down 80.05% YoY) and the FY2025 annual result came in at $241.4 million, down 43.77% from the prior year.
- Net Equity Issued and Repurchased declined to -$44000.0 in Q1 2026, from $48.2 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $241.4 million in Q1 2025 to a low of -$44000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Arrowhead Pharmaceuticals | 12.23 Bn | 10.63 Bn | - | 28.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.00 Mn |
| Jun 30, 2026 | 28.00 Mn |
| Mar 31, 2026 | -44,000.00 |
| Mar 31, 2026 | -44,000.00 |
| Dec 31, 2025 | 48.20 Mn |
| Dec 31, 2025 | 48.20 Mn |
| Mar 31, 2025 | 241.39 Mn |
| Mar 31, 2025 | 241.39 Mn |
| Mar 31, 2020 | -21,000.00 |
| Mar 31, 2020 | -21,000.00 |
| Dec 31, 2019 | 250.50 Mn |
| Dec 31, 2019 | 250.50 Mn |
| Jun 30, 2019 | 60.52 Mn |
| Jun 30, 2019 | 60.52 Mn |
| Mar 31, 2019 | 60.52 Mn |
| Mar 31, 2019 | 60.52 Mn |
| Dec 31, 2018 | 60.52 Mn |
| Dec 31, 2018 | 60.52 Mn |
| Jun 30, 2017 | -272,818.00 |
| Jun 30, 2017 | -272,818.00 |